263 related articles for article (PubMed ID: 32562805)
1. Enzyme-responsive polymeric micelles of cabazitaxel for prostate cancer targeted therapy.
Barve A; Jain A; Liu H; Zhao Z; Cheng K
Acta Biomater; 2020 Sep; 113():501-511. PubMed ID: 32562805
[TBL] [Abstract][Full Text] [Related]
2. Self-assembled micelles of novel amphiphilic copolymer cholesterol-coupled F68 containing cabazitaxel as a drug delivery system.
Song Y; Tian Q; Huang Z; Fan D; She Z; Liu X; Cheng X; Yu B; Deng Y
Int J Nanomedicine; 2014; 9():2307-17. PubMed ID: 24872693
[TBL] [Abstract][Full Text] [Related]
3. Cancer-targeted and glutathione-responsive micellar carriers for controlled delivery of cabazitaxel.
Han X; Gong F; Chi L; Feng C; Sun J; Chen Y; Liu J; Shen Y
Nanotechnology; 2019 Feb; 30(5):055601. PubMed ID: 30511654
[TBL] [Abstract][Full Text] [Related]
4. Engineering folate-targeting diselenide-containing triblock copolymer as a redox-responsive shell-sheddable micelle for antitumor therapy in vivo.
Behroozi F; Abdkhodaie MJ; Abandansari HS; Satarian L; Molazem M; Al-Jamal KT; Baharvand H
Acta Biomater; 2018 Aug; 76():239-256. PubMed ID: 29928995
[TBL] [Abstract][Full Text] [Related]
5. Targeting prostate cancer with docetaxel-loaded peptide 563-conjugated PEtOx-co-PEI
Nezir AE; Bolat ZB; Ozturk N; Kocak P; Zemheri E; Gulyuz S; Ozkose UU; Yilmaz O; Vural I; Bozkır A; Sahin F; Telci D
Amino Acids; 2023 Aug; 55(8):1023-1037. PubMed ID: 37318626
[TBL] [Abstract][Full Text] [Related]
6. Formulation of Acid-Sensitive Micelles for Delivery of Cabazitaxel into Prostate Cancer Cells.
Aydin O; Youssef I; Yuksel Durmaz Y; Tiruchinapally G; ElSayed ME
Mol Pharm; 2016 Apr; 13(4):1413-29. PubMed ID: 26977718
[TBL] [Abstract][Full Text] [Related]
7. Marked response to cabazitaxel in prostate cancer xenografts expressing androgen receptor variant 7 and reversion of acquired resistance by anti-androgens.
Ylitalo EB; Thysell E; Thellenberg-Karlsson C; Lundholm M; Widmark A; Bergh A; Josefsson A; Brattsand M; Wikström P
Prostate; 2020 Feb; 80(2):214-224. PubMed ID: 31799745
[TBL] [Abstract][Full Text] [Related]
8. Alendronate-functionalized hypoxia-responsive polymeric micelles for targeted therapy of bone metastatic prostate cancer.
Long M; Liu X; Huang X; Lu M; Wu X; Weng L; Chen Q; Wang X; Zhu L; Chen Z
J Control Release; 2021 Jun; 334():303-317. PubMed ID: 33933517
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of enzyme-responsive theranostic amphiphilic conjugated bottlebrush copolymers for enhanced anticancer drug delivery.
Liu F; Wang D; Zhang M; Ma L; Yu CY; Wei H
Acta Biomater; 2022 May; 144():15-31. PubMed ID: 35306183
[TBL] [Abstract][Full Text] [Related]
10. Enzyme and Redox Dual-Triggered Intracellular Release from Actively Targeted Polymeric Micelles.
Zhang L; Wang Y; Zhang X; Wei X; Xiong X; Zhou S
ACS Appl Mater Interfaces; 2017 Feb; 9(4):3388-3399. PubMed ID: 28071889
[TBL] [Abstract][Full Text] [Related]
11. Multinucleation and Mesenchymal-to-Epithelial Transition Alleviate Resistance to Combined Cabazitaxel and Antiandrogen Therapy in Advanced Prostate Cancer.
Martin SK; Pu H; Penticuff JC; Cao Z; Horbinski C; Kyprianou N
Cancer Res; 2016 Feb; 76(4):912-26. PubMed ID: 26645563
[TBL] [Abstract][Full Text] [Related]
12. Tumor-targeting peptide conjugated pH-responsive micelles as a potential drug carrier for cancer therapy.
Wu XL; Kim JH; Koo H; Bae SM; Shin H; Kim MS; Lee BH; Park RW; Kim IS; Choi K; Kwon IC; Kim K; Lee DS
Bioconjug Chem; 2010 Feb; 21(2):208-13. PubMed ID: 20073455
[TBL] [Abstract][Full Text] [Related]
13. TROPIC: Phase III trial of cabazitaxel for the treatment of metastatic castration-resistant prostate cancer.
Oudard S
Future Oncol; 2011 Apr; 7(4):497-506. PubMed ID: 21463139
[TBL] [Abstract][Full Text] [Related]
14. Tumoral acidic extracellular pH targeting of pH-responsive MPEG-poly(beta-amino ester) block copolymer micelles for cancer therapy.
Ko J; Park K; Kim YS; Kim MS; Han JK; Kim K; Park RW; Kim IS; Song HK; Lee DS; Kwon IC
J Control Release; 2007 Nov; 123(2):109-15. PubMed ID: 17894942
[TBL] [Abstract][Full Text] [Related]
15. A polymeric micelle with an endosomal pH-sensitivity for intracellular delivery and enhanced antitumor efficacy of hydroxycamptothecin.
Pu X; Zhao L; Li J; Song R; Wang Y; Yu K; Hou X; Qiao P; Zong L; Chang S
Acta Biomater; 2019 Apr; 88():357-369. PubMed ID: 30822554
[TBL] [Abstract][Full Text] [Related]
16. The Wnt non-canonical signaling modulates cabazitaxel sensitivity in prostate cancer cells.
Sennoune SR; Nelius T; Jarvis C; Pruitt K; Kottapalli KR; Filleur S
PLoS One; 2020; 15(6):e0234078. PubMed ID: 32484838
[TBL] [Abstract][Full Text] [Related]
17. PSMA-mediated endosome escape-accelerating polymeric micelles for targeted therapy of prostate cancer and the real time tracing of their intracellular trafficking.
Gao Y; Li Y; Li Y; Yuan L; Zhou Y; Li J; Zhao L; Zhang C; Li X; Liu Y
Nanoscale; 2015 Jan; 7(2):597-612. PubMed ID: 25419788
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, in vitro characterization, and anti-tumor effects of novel polystyrene-poly(amide-ether-ester-imide) co-polymeric micelles for delivery of docetaxel in breast cancer in Balb/C mice.
Varshosaz J; Enteshari S; Hassanzadeh F; Hashemi-Beni B; Minaiyan M; Mirsafaei R
Drug Dev Ind Pharm; 2018 Jul; 44(7):1139-1157. PubMed ID: 29436875
[TBL] [Abstract][Full Text] [Related]
19. Cabazitaxel regimens inhibit the growth of prostate cancer cells and enhances the anti-tumor properties of PEDF with various efficacy and toxicity.
Jarvis C; Nelius T; Martinez-Marin D; Sennoune SR; Filleur S
Prostate; 2018 Sep; 78(12):905-914. PubMed ID: 29749077
[TBL] [Abstract][Full Text] [Related]
20. pH-responsive polymeric micelles based on poly(2-ethyl-2-oxazoline)-poly(D,L-lactide) for tumor-targeting and controlled delivery of doxorubicin and P-glycoprotein inhibitor.
Zhao Y; Zhou Y; Wang D; Gao Y; Li J; Ma S; Zhao L; Zhang C; Liu Y; Li X
Acta Biomater; 2015 Apr; 17():182-92. PubMed ID: 25612838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
